Annual report [Section 13 and 15(d), not S-K Item 405]

REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)

v3.26.1
REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)
12 Months Ended
Dec. 31, 2025
REVENUES FROM CONTRACTS WITH CUSTOMERS  
Schedule of disaggregation of net revenues

  ​ ​ ​

Year Ended December 31, 

($ in thousands)

  ​ ​ ​

2025

  ​ ​ ​

2024

EmrosiTM

$

14,745

$

Qbrexza®

25,014

25,114

Accutane®

12,882

19,407

Foam franchise products (Amzeeq® & Zilxi®)

5,859

6,652

Other / legacy

2,739

3,961

Total product revenues

$

61,239

$

55,134

Schedule of other revenue

  ​ ​ ​

Year Ended December 31, 

($ in thousands)

2025

  ​ ​ ​

2024

Milestone payment from Cutia

$

$

1,000

Cutia supply agreement

 

606

Royalties on sales of Amzeeq by Cutia

13

Total other revenue

$

619

$

1,000